Skip to content

Exosomes injection on poor responder ovary

Effectiveness of intraovarian injection of exosomes derived from mesenchymal cells in infertile women with poor ovarian response

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002576N37
Enrollment
60
Registered
2024-03-25
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor ovarian response. Female infertility of other origin

Interventions

Intervention 1: Intervention group: exosomes will be injected in the ovarian tissue by transvaginal ultrasonographic guidance at the day of oocyte punctuer under anesthesia after three months, ovarian

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Abnormal ovarian reserve test Antral follicle count <5 At least one previous IVF cycle <3 oocyte was retrieved.

Exclusion criteria

Exclusion criteria: Ovarian insufficiency due to gonadal dysgenesia and abnormality of chromosoms Male infertility

Design outcomes

Primary

MeasureTime frame
AMH. Timepoint: Three months after intervention. Method of measurement: Blood test.;FSH. Timepoint: Three months after intervention. Method of measurement: Blood test.;Number of oocyte. Timepoint: Three months after intervention. Method of measurement: Follicle counts in transvaginal sonogram.

Secondary

MeasureTime frame
Biochemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: ?BhCG measurement.;Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Fetal heart activity in transvaginal sonogram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026